Tiger BioSciences highlights a series of major clinical and scientific achievements resulting from the company's expanded investment in evidence‑based research throughout 2025. This strategic focus has strengthened Tiger BioSciences' position as a market leader heading into 2026, with a portfolio increasingly defined …
Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) to Shonan Health Innovation Park (Shonan iPark) in January 2027. The move will strengthen the company’s global R&D capabilities for its pharmaceuticals business and accelerate open innova…
BizClik will launch HR Chief in February 2026 as a global platform focused on the future of work, leadership and organisational culture. HR Chief will examine how major organisations are redesigning work in an era shaped by generative AI, hybrid operating models, new regulatory demands and talent competition. Coverage…
Baird Medical Investment Holdings Ltd., a market leader in Microwave Ablation (MWA) technology, announced the establishment of a dedicated manufacturing base in the United States. This development marks a pivotal step in Baird Medical's transition from a specialized exporter to a comprehensive global medical technolo…
BaseLaunch, a platform to launch, fund, and build early biotech ventures developing cutting-edge therapeutics, announced Takeda has joined the Basel-based incubator, bringing the total number of leading pharma company partners to six. Through its strategic investment in BaseLaunch, Takeda gains access to proven qual…
NXTUS, Inc., along with HTA, introduced HealthCatalyst NWA, a unique innovation program designed to expand growth opportunities for early-stage companies and make Northwest Arkansas a proving ground for technology tools addressing pressing needs in health and economic vitality. The Walton Family Foundation awarded NX…
ICON plc , a world-leading clinical research organisation, released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey, while the second survey focused exclusively on trends in the rapidly growing Chinese biotech market. In total, both survey…
Employers will face significant risks to employee well-being if grind culture and demoralization are not addressed, according to meQuilibrium (meQ), the world's leading workforce resilience expert. On the bright side, deskless workers will lead the charge on self-improvement, and employers will prioritize proactive re…
Futuro Health, has received a $1 million commitment from JPMorganChase to launch a national Healthcare Workforce Resilience Initiative (HWRI). Through this Initiative, Futuro Health will help employers build their workforce by providing current and prospective employees with the in-demand credentials and qualification…
Pillar Biosciences and AstraZeneca announced an expansion of their existing laboratory access program for NGS-based kitted liquid biopsy tumor profiling to include China. This expanded collaboration aims to deliver rapid, cost-effective, and clinically actionable genomic insights through liquid biopsy testing. By inc…
Page 10 of 55